Dr. Shehneela Dar (MD)
Director, Medical Research
Canadian Journal of Scientific and Clinical Discovery (CJSCD)
Toronto, Canada
Professional Biography
Dr. Shehneela Dar serves as the Director of Medical Research at "the
Canadian Journal of Scientific and Clinical Discovery (CJSCD)" based in Toronto,
Canada. Her work spans several critical domains of clinical science, with a
strong focus on cardiology, diabetes, hypertension, and polycystic kidney
disease. Dr. Dar’s research emphasizes the integration of molecular insights
with clinical practice, advancing early diagnostic strategies, innovative
therapeutic approaches, and long‑term patient outcome improvement. Through her
leadership at CJSCD, she contributes to strengthening scientific rigor,
fostering interdisciplinary collaboration, and promoting high‑impact clinical
research within the global medical community.
Research Profile
Dr. Dar’s research program centers on the intersection of cardiovascular
medicine, metabolic disorders, and renal pathophysiology. Her work employs
translational approaches that bridge fundamental biological mechanisms with
clinical application. She is particularly engaged in identifying early
diagnostic markers, evaluating emerging therapeutic strategies, and improving
long‑term outcomes for patients with chronic cardio-metabolic and renal
conditions. Her contributions support evidence‑based clinical practice and
advance interdisciplinary scientific discovery.
Clinical Interests
Cardiology
. Management of heart failure,
arrhythmias, and ischemic heart disease.
• Preventive
cardiology with emphasis on risk‑factor modification and patient‑centered care.
Diabetes
• Clinical
management of Type 1 and Type 2 diabetes.
• Metabolic
dysregulation and insulin resistance.
• Prevention
of diabetes‑related cardiovascular and renal complications.
Hypertension
• Diagnosis
and long‑term management of hypertension.
• Mechanisms
of blood pressure regulation.
• Vascular
remodelling in hypertensive populations.
Polycystic Kidney Disease (PKD)
• Early
detection and renal function preservation.
• Clinical
monitoring of PKD progression.
• Integration
of genetic and molecular insights into patient care.
Scholarly Focus
• Molecular
and physiological mechanisms underlying cardio-metabolic diseases.
• Transnational research linking laboratory findings to clinical interventions.
• Development
and evaluation of novel diagnostic and therapeutic modalities.
• Longitudinal
studies on disease progression in diabetes, hypertension, and PKD.
• Interdisciplinary
collaboration across cardiology, nephrology, and metabolic medicine
• Advancement
of clinical research methodologies within scientific and peer‑reviewed
publishing
